6088: Maximizing Patient Safety While Minimizing the Risk of Prescribing Controlled Drugs
Course Description
This course will qualify for the mandatory Tennessee CME requirement for prescribing controlled substances. The course begins with a brief overview of the overdose epidemic. The course includes a review of the anatomic illustration and physiologic explanations of where opioids, amphetamines and other controlled medications work in the brain and body; why exposure to these classes of medications can cause euphoria and precipitate addiction; and the confusing nomenclature of addiction and substance use disorders. Tennessee rules and regulations (including the Tennessee Chronic Pain Guidelines) regarding prescribing opioids, amphetamines and other controlled medications will be examined. The complexity of chronic pain will be explained using a categorical system. Clinical vignettes are shown to illustrate these concepts.
Learning Objectives
- Identify the areas of the brain and neurotransmitters responsible for addiction
- Utilize the Tennessee chronic pain guidelines and other regulations to maximize patient safety while minimizing the risk of prescribing controlled substances
- List the categories of a range of pain syndromes
Credit Awarded
- 2.0 hours of mandatory controlled substances CME credit for Tennessee physicians
- 10% Premium Credit for Physician Policyholders
- Certificate of Participation for Non-Physicians
CME Information
Accreditation: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Tennessee College of Medicine (UTCOM) and State Volunteer Mutual Insurance Company. The UTCOM is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation: The UTCOM designates this live activity for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AOA: This program is eligible for two (2) credit hours in Category 2 of the Continuing Medical Education Program of the American Osteopathic Association. Physicians will need to submit a letter of completion from the University of Tennessee directly to the AOA to receive CME credits.
AAFP: The AAFP has reviewed Maximizing Patient Safety While Minimizing the Risk of Prescribing Controlled Drugs, and deemed it acceptable for AAFP credit. Term of approval is from 03/11/2022 to 12/31/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education for Non-Physicians: Non-physicians can obtain continuing education credits for attending activities that award AMA PRA Category 1 Credit(s)™ to physicians. Check with your licensure/certification board for confirmation. A Certificate of Participation will be sent to all non-physicians.
CME Disclosures
No commercial support was received for this activity. No speakers plan to discuss off-label use. No planners or speakers have relevant financial relationships to disclose.